Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F X Vollenweider

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.
Human Brain Mapping|September 18, 2001
Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)E Frei, A Gamma, R Pascual-Marqui, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosisF X Vollenweider, K L Leenders, C Scharfetter, et al.
Therapeutic Drug Monitoring|February 1, 1995
Development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samplesN Feng, F X Vollenweider, E I Minder, et al.
Neuroreport|February 23, 2000
Mood state and brain electric activity in ecstasy usersA Gamma, E Frei, D Lehmann, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)F X Vollenweider, K L Leenders, C Scharfetter, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2000
Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: assessment of methodsA Buck, P M Gucker, R D Schönbächler, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 24, 2009
GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studiesF Hasler, O F Kuznetsova, R N Krasikova, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.
Human Brain Mapping|September 18, 2001
Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)E Frei, A Gamma, R Pascual-Marqui, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1997
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosisF X Vollenweider, K L Leenders, C Scharfetter, et al.
Therapeutic Drug Monitoring|February 1, 1995
Development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samplesN Feng, F X Vollenweider, E I Minder, et al.
Neuroreport|February 23, 2000
Mood state and brain electric activity in ecstasy usersA Gamma, E Frei, D Lehmann, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)F X Vollenweider, K L Leenders, C Scharfetter, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2000
Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: assessment of methodsA Buck, P M Gucker, R D Schönbächler, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 24, 2009
GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studiesF Hasler, O F Kuznetsova, R N Krasikova, et al.
Pageof 4